{"chunk_id": "8f105387-ff45-43d5-a7b7-38c3f46d7f74", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "CLINICAL PRACTICE GUIDELINES\nCHILDHOOD IMMUNISATION\n\u2018Ths gudetine smear to be gue for cnc pact, based on the best vale\nevicence a the time of development. Adherence to this guideline may not\nessay entre the best outcome In every cata Every heath cate prover Ie\nrespon forthe management of hive unique patient based on the cia\nPc preserte byte patarit anl the managerent options ave oal\nThs gute was ised in September 204 and wel be reviewed in September\nes orsooner# new dence Dec wala. rs Secreta\n\u2018oven Techeology Assessment Unt\nHedcal Developme Dison\nMossy of Heath asi\n2s Flo Bangunan AKA\nJatpos\nSi200 cata Lumpur\nabla teflon bie ip worumah ou\nwtp wacom agar\nGUIDELINES DEVELOPMENT AND OBJECTIVES. Guideline Development\nThe work gioup fr the dovelopment of tose gudaines comprised\npaodatcians fom various Minty of Heal facies. These gues\nSe based onthe fodings of health ectinlogy orsosemant on he sae\n\u2018opi, 25 wel as a systematic review of caert medial Herat. The\n\u2018ranking of exdonoe Is Daned on modified vrson of fat suggested by\nthe Catalonia Agency for Hoan Tocmncogy Assessment nd Research\n(CANTAR) Spain, while the grading of recommendations in those\n\u2018uldetnss emulates that wed by the Scotian Inaycomgiat\u00bb Gudanos\nNetwot (SIGN). The daft gudalines were posted on both the Niniy\n\u2018of Heat Malaysia and Academy of Medicine, Malaysia wobste for\nomment and feedback. Those guidlines have also been presented \u00a9\nthe Technical Advsory Commitee for Clsical Pract Gudolines ane\nHealth Tecmsology Assossmont and Canal Pracice Guselnes\n(Counes, Misty of Heath Milaysia fr review and approval\nObjective\n\u2018Tho aim of his gin is oa heath caro providers in gonora\nraces and pedatcians, in cdl decison making by providing wall\nEstanesd evidence bated infmaton on chikdhod emanieaton Ilsa\nhoped to doctease he ncilence of compicatona. \u201cTarget Population\n\u201cThis guideline Is dovoloped to apply oa chron,\n\u2018Target Group\nThis guideline fs meant for a heath care proves,\nithod inaiston\nLEVEL OF EVIDENCE SCALE\n\u2018Strength of \u2018Study design\nlevsance,\nGood TORT, Systema Tovow\nine Good | Large ameio RET\nL\n7 Sia sanelo ROT\nI 00d 0 Fair\nfa Non andonised conoied prospective Wal\nTon andonised convaied prospec Wal wit\nato!", "chunk_order": 0}
{"chunk_id": "b275c8b5-cf17-4180-ae0c-430b2e00e205", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "\u201cTarget Population\n\u201cThis guideline Is dovoloped to apply oa chron,\n\u2018Target Group\nThis guideline fs meant for a heath care proves,\nithod inaiston\nLEVEL OF EVIDENCE SCALE\n\u2018Strength of \u2018Study design\nlevsance,\nGood TORT, Systema Tovow\nine Good | Large ameio RET\nL\n7 Sia sanelo ROT\nI 00d 0 Fair\nfa Non andonised conoied prospective Wal\nTon andonised convaied prospec Wal wit\nato! control\nD Far] Cott uo\n7 Poor] Case conta ataios\n: Poor | NERO i, ec\nExpat Somos, consensus, cava ropa,\n\u00ae Poor | anecdotes\n(Raiied Fam, Caan Aa Tr Fat Toslay Resse &\nRescorch,(CAHTARY Soa)\nGRADE OF RECOMMENDATIONS\nToast one meta analysis, systemate review, of RCT, or ovdence\na good and \u00e9rectyappleabl te he rget popuation\n1p Fence rm well condcted cine inal, drocy applicable othe\nPopulation, and demonstrating vera constancy of resis:\noxtapoiated fom meta anal, sytem ovow, of RCT\n[Evidence rom exper commie parts, or oplniens and/or niet\n| \u00a9 letpetiences of respect authoatos: india abaance of drecly\n| em stadlos of good ualty\n(Adopted tom Scots tarcdeate Guten Network (SIGND\nsind ime\nGUIDELINES COMMITTEE\nDr Tan Kah Koo\nConstant Paediatrician\nDepartment of Poodatis\nSeremban Hospiat\nr Wong Smee Lan\nConsultant Paediatrician\nDeparment of Poedatics\nSorersban Hospital\nOr Kuan Gok Lan\nConsstant Paodaincin\nDepartment of Paediates\n\u2018Malacca Hesptt\nDr Zainah Shak Hod\nConstant Pacdatigan\nDeparment of Paedatics\nMalocea Hospital\nDate\u2019 Or Jinmy Lee Kok Fo\nConstant Pacdatican\nDoparimort of Poetics\nKuala Terenggana Hospital\nDr Hang Long C00\nConstant Paesiatcian\nInatve of Paosstien\n\u2018ala Lumpur Hespiat\nDe Naat Shims\nFamby Hoa Development Division\nMoisty of Healt Malaysia\nGuidelines Coordint\nMe Sin Lin Thye\nusing Stor\n\u2018oath Tecnology Assessment Unit\nMisty of Heath Naaysia\nead, Health Technology Assessment Unit\nDeputy Drcto,\nMedical Development Division\nintr of Heath Malaysia\n\u2018TABLE OF CONTENTS. (CHILDHOOD iMMUNISATION\nTABLES\n\u2018able 1 EPI sehedie\nTable 2 New immurssatin schedule\nTable 3 Recommended immunsation schedule\n\u201cInmactoetetent crn\neco\nINTRODUCTION\nADVERSE EFFECTS:\n21 Md Adverse Events\n22 _Sovore Adverse Evens\nVACCINE EFFICACY\n'STORAGE AND ADMINISTRATION\nIMMUNISATION SCHEDULE\nSPECIAL SITUATIONS\n1 Premature and Low Binh Weight Babies\n2 Babies oem to HV postve motors\nDIPHTHERIA, TETANUS AND PERTUSSIS. 4. rROQUCTION\n1 Dihiheria\n12\u00b0 Totanas\n13 Parts\n14 OPT Vaccine\n2 ADVERSE EFFECTS\n24 Systemic Reactions\n3. VACCINE EFFICACY\n31 Dipiaria Vaccine\n32. Tetanus Toso Vaccine\n33 Pertussis Vaccine\n4. STORAGE. DOSAGE AND ADMINISTRATION\n41 Daphnia Vaccine\n$2 Tetanvs Toso\u2019\n43 Pertussis Vaccine\n5 RECELERATED OTP MMUNISATION SCHEDULE\nPOLIOVIRUS VACCINE\nlrRooucTON\nADVERSE EFFECTS\nVACCINE EFFICACY\n\u2018STORAGE, DOSAGE AND ROUTE OF ADMINISTRATION\nSCHEDULE\nSPECIAL SITUATIONS\nNEPATITISB VACCINE\nINTRODUCTION\nADVERSE EFFECTS. VACCINE EFFICACY\n\u2018STORAGE, DOSAGE AND ADMINISTRATION\n\u2018SPECIAL SITUATIONS\n5.1. Infants Bom to HosAg Positive Methors\n82) Proton want\n53. SerogieTestng\nHAEMOPHILUS INFLUENZAE VACCINE\nWwTRODUCTION\nADVERSE EFFECTS. \u2018VACCINE EFFICACY\nCOMBINATION OF VACCINES. \u2018STORAGE, DOSAGE AND ROUTE OF ADMINISTRATION\n\u2018SCHEDULE\n\u2018SPECIAL SITUATIONS\n71 Promature Babies\n7.2 Thaassasmia and Splonecomy\n73. HWVinfecson\nMEASLES, MUMPS AND RUBELLA VACCINE\ninTRoDUGTION\n11 Meas\n12 Mumps\n13\u00b0 Ribot\n13 MMR Vaccing\nADVERSE EFFECTS. \u2018VACCINE EFFICACY\n\u2018STORAGE, DOSAGE AND ROUTE OF ADMINISTRATION\n\u2018SCHEDULE.", "chunk_order": 1}
{"chunk_id": "8a629592-d2c0-4e5a-870a-7162cc7cbcdd", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "VACCINE EFFICACY\n\u2018STORAGE, DOSAGE AND ADMINISTRATION\n\u2018SPECIAL SITUATIONS\n5.1. Infants Bom to HosAg Positive Methors\n82) Proton want\n53. SerogieTestng\nHAEMOPHILUS INFLUENZAE VACCINE\nWwTRODUCTION\nADVERSE EFFECTS. \u2018VACCINE EFFICACY\nCOMBINATION OF VACCINES. \u2018STORAGE, DOSAGE AND ROUTE OF ADMINISTRATION\n\u2018SCHEDULE\n\u2018SPECIAL SITUATIONS\n71 Promature Babies\n7.2 Thaassasmia and Splonecomy\n73. HWVinfecson\nMEASLES, MUMPS AND RUBELLA VACCINE\ninTRoDUGTION\n11 Meas\n12 Mumps\n13\u00b0 Ribot\n13 MMR Vaccing\nADVERSE EFFECTS. \u2018VACCINE EFFICACY\n\u2018STORAGE, DOSAGE AND ROUTE OF ADMINISTRATION\n\u2018SCHEDULE. SPECIAL SITUATIONS. {6.1 Measlas Immunisation in IV Infected Chien:\n6.2._Steroid Treatment\nREFERENCES. 2\nfs\n5\n6\n6\n6\n1%\n%\n0\no\n\u00b0\nPEEEEDEEeEeT yy)\nnnd meat\n\u2018CHILHOOD IMMUNISATION\nImmunisation isan attempt to roplaco the anticipated natural pimary\n\u201cconic batwoan the human Body and a hosto organi. wt lor\nStic contact, so that any subsequent naturel contact takes place ina\nStale of hoghtoned immunity. Whlo advances in publ heath ad\n\u2018medicine have reduced he morbid and mortality ates accompanying\nGeran Infoctous diseases, immuntsation represents the single ost\n\u2018mass approach to prevention (Zimmerman, 1987)\nTho World Heath Organisation (WHO) Expanded Programme on\nInmunatn (EPN) recommends tat \u2018| counties immunise agalnst\nDolomiti, dehera, porussis, tears, meaues, and tuberculoes\n{Te} foc in counties witha high inedncs. In ado. Hepaits 8\n\u201caceine was tobe inlograted to rations munsaton programm\n\u2018al cous by 1997 (testy of Heath Malays, 2002, ove?)\nTable 1; EP achadule\nTae ican epg 8 Varig\n\u2018Sone\naa OG, OPV\nSooo Der sort ves\ntoweoks ber 2 opv2 Kez\nett\n{5 vor segs fom Sth ha) tos chen 0 for Davo woh se Pee\nointl aremstn (9 Sub-saaran e)\n\u2018has generally boon accopted that no immurisatonschedula fs dea. \u2018and us tho EPI rocommands thal each courry dotmine A OMe\nSched tat bost su is needs. Tho eatoge quing principle of any\nimmunisation programme is that potecson must be achieved balore\ninfants are a high sk of @ diseaso. In most developing counties,\n\u2018deases lnluded wit the EPI stike gary I io, ond thus\nimportant io protct chron Beough immunisation 25 oary as possible. [Apt toni, any mena ached represents sem degree\nCompromise. In addon, wile acknowadging thet seroconversion =\n\u20189ge-dopondont, ho omphasis shoud be on blaring protection Inthe\ninfant at as young an age as pasate (tris of Heath Malaysia, 2002,\nfave! \u2018Tho iemunsaton programm in Malaysia commonced about 40 years\n\u2018go with the OPT vaccine, Ts was fotowed by be BCS vaccine\n4961 and tho OPV vacsine a 1972. Meas enmunisaton was added\nsind nme\n'o the programme in 1984, wih immunisation against rubella being\nInrocused i 1088 and against bepatta Bm 189 (Patnanathan,\n1300), The immunisaton coverage for Malaysia was 99.97% tor BCG,\n96.9% for OPT (hea dose}, 54% for OPV (hed dose), 88.4% for\nfmoases snd 895% for hepaits \u00a9 (Bid dose) io 2000 (Misty of\nFoam Malaysia, 2002, love 1).", "chunk_order": 2}
{"chunk_id": "3dcd750a-4a5c-4c24-a931-44199a1ef395", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "\u2018Tho iemunsaton programm in Malaysia commonced about 40 years\n\u2018go with the OPT vaccine, Ts was fotowed by be BCS vaccine\n4961 and tho OPV vacsine a 1972. Meas enmunisaton was added\nsind nme\n'o the programme in 1984, wih immunisation against rubella being\nInrocused i 1088 and against bepatta Bm 189 (Patnanathan,\n1300), The immunisaton coverage for Malaysia was 99.97% tor BCG,\n96.9% for OPT (hea dose}, 54% for OPV (hed dose), 88.4% for\nfmoases snd 895% for hepaits \u00a9 (Bid dose) io 2000 (Misty of\nFoam Malaysia, 2002, love 1). The now recommended immunaation\n\u2018shod a9 tsraed in Table 2 bolow:\nTable 2: New immunisation schoduo\ni ee\nFor immunodefisant chien, the recommended schedule Is shown\nbelow\n\u201cTable 3 Recommended Immunisation Shed frrmunodeictnt\n\u2018Chidren|\n[mimantation | Tmmunosuppresive wv | Banga\nL therapy Contacts\nBC. No. Hep Yes\nPT Yes. \u2018OPV No\nco Yea > Boar\n- ose)\n| oasios wo T\n|\nor Ne T\nBCG VACCINE\n4. INTRODUCTION. In Malaysia, the incidence of tuberculosis was 63.6 por 100,000\n\u2018opuition i 1997, and has oon increasing stony sien 1905, Tho\n\u2018most important souree of human inecton fs an infected person who\n\u2018Spreads the high Infecous baci through respiratory dopa, Primary\n{ocsons occur at any 9, most often In chien, may ba\n_asymotomatic, and ressive spontaneousy. Homever it may also spread\nnd caso diioavo in varous organs Incuding ngs, menges. bones\n\u2018and Boodeteam (Minit of Hoatn Malaysia, 2002, vel 1),\n\u2018Te Bacile Calmette-Guerin (BCG) vaccine is ae attonsated stan of\nMycobactorum bovis, contaring no aduvant oF preservative excoot\n\u2018monssodiam glamale or atumin as the stablzer. Tho aon othat\nSaino coktion or sailed waler WHO. recommends. that bo\n\u2018Sdmaitored a ith and is cuendy used i more thon 100 counties\n(0, 2000 foe! 1). 2. ADVERSE EFFECTS\nFollowing intradermal injocton, lal acon \u00e9s normal, \u00a9 papue\nforming win 2-3 wooks, with uation at 6.8 weeks, flowed by 2\n\u2018scr a tho and of 3 month, The adverse events ar precomnany\n\u2018elated 10 infection by be five atteruates bacea, as wl as being Ge\n{o crore in achieving ita-doomal ocuation. They ea be classed a\n\u2018mild and severe events and ae elaborated on 260m. 2.4 Mild Adverse Events\nThe most common adverse effect of subcutanwous injection i a local\n_abscass White moro extoisve and prolonged cal veactons ca ocr,\nSncondary nfoctons atthe to of injoctons ao unlikely Somes,\nSry or coral fymphadenits may develop. However. n most casos\nitheats spantancoust. and no Weatmont fs required. In exome cases,\nsystemic toatment wih ertromycin Yor up 10 one tri may be\nhelp in cases with achovent or fisted impact canage\n\u2018ay be caried out and anbtuborsous drugs inated Heal, although\n\u2018Syslome art ubercuous drags ave notlactive. 22. Severo Adverse Events\n\u2018Systemic infecton by BCG Is 2 recognized but rare consaquance of\n\u2018raconation. an oly soon m chisron wh sovare mena defenses\n\u201cuch as Severe Combaned immune Defesency, Chrone Granulomatous\nSiseaso oF D1 George syndrome.", "chunk_order": 3}
{"chunk_id": "700aab21-ceaa-408d-aee3-62d521240287", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "However. n most casos\nitheats spantancoust. and no Weatmont fs required. In exome cases,\nsystemic toatment wih ertromycin Yor up 10 one tri may be\nhelp in cases with achovent or fisted impact canage\n\u2018ay be caried out and anbtuborsous drugs inated Heal, although\n\u2018Syslome art ubercuous drags ave notlactive. 22. Severo Adverse Events\n\u2018Systemic infecton by BCG Is 2 recognized but rare consaquance of\n\u2018raconation. an oly soon m chisron wh sovare mena defenses\n\u201cuch as Severe Combaned immune Defesency, Chrone Granulomatous\nSiseaso oF D1 George syndrome. Other rare adverso evans chee\n[BCC ostetis and esteomyets (WHO, 1998; 1999, 2000, vel 1)\n3. VACCINE EFFICACY\n[BCS vaccine has high protective affleacy (approximately 90%) aginst\n\u2018moringoal and ilar tuberculosis in esto. Homver tho protecive\nCticacy agains! pulmonary asoase ls varlabl, ranging ram O% 0 80%,\n\u2018wha lower dope of rtachon i topical egiors(mencan Academy\n\u2018ot Pedals, 2000; WHO, 1999, lve). 4. STORAGE AND ADMINISTRATION\nBOG vaccine should be stored and wansported at 2C 10 &\u00b0C. The\n\u2018dives should not be frozon but Kopt coo. The vaccine must be Kept\nfotrgerae. and once the civent hae been added sed win 4 Nou,\nland opt away tom ight (Academy ef Mocicine of Malaysia, 2001. \u2018Adminstration of BCS vaccine is tough ira-demal wjeton with 3\n25.026 gauge need atthe dtd ropion ofthe upper ar, which wil\nIinmize post vaconation lymphadenopathy. Other less satsaciry\nTachagues ute porewanecus iyacions and Use of ft Injectors OF\n\u2018ifreated needs,\n5, IMMUNISATION SCHEDULE\n[BCG is cureny recommended at bith, of at fst contact wit neath\nServices. Tore ste scent evidence on the affeay of booster\n\u2018otos for BEG WHO, 1088, 1098 love!) (Grade A\n6. SPECIAL SITUATIONS\n6.4 Premature and Low Bith Weight Babies\nInfants less than 33 weeks at less aly to develop BCG scar and a\n\u2018oacivo PPD luborcu test aor BCG vacsnaton Prmalire Dabo\nthus need not be given BCG vaccine unl ay ae a loaet 34 woeks,\nand wih body weight more than 4800 to 2000 \u00a2 (Sedaghatan etl,\n5098, fove! 0) (Grade C\n162 _Bablos born to HV positive mothers\nBBC should not be admelerd to chlren wih symptomatic HIV\ninfecton. However, for babies bom fo HIV positve motor, since the\nHIV status earmot bo dolermined al bth, es none are Ikely to have\n\u2018Symetoms of HIV infecion, WHO recommends that they be\n\u2018dmanisteed BCG. vaccine, especialy Ih afoas where the ak of\nTuberulss i igh (WHO, 1998; 1000, evel 7) [Grade A]\nDIPHTHERIA, TETANUS AND PERTUSSIS\nrRODUCTION\n1. Diphtheria\nDotnet an ni intectiousdasase aflactng tho upper respieaory\n\u2018act and occasionally skin, vagna nd conjunciva, The cles! tmarifestations result tem ho acton ot an exotoxin rodiced Dy\nConmnebacteum dihtharie, Diphtheria is acquired tough personal\n\u2018contac. the incubation peiod being genaaly 2 40 5 days. Iie a\nToile disease in Malaysia.", "chunk_order": 4}
{"chunk_id": "f12affcc-1af3-452f-9be0-d882cbe5c7d6", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "vaccine, especialy Ih afoas where the ak of\nTuberulss i igh (WHO, 1998; 1000, evel 7) [Grade A]\nDIPHTHERIA, TETANUS AND PERTUSSIS\nrRODUCTION\n1. Diphtheria\nDotnet an ni intectiousdasase aflactng tho upper respieaory\n\u2018act and occasionally skin, vagna nd conjunciva, The cles! tmarifestations result tem ho acton ot an exotoxin rodiced Dy\nConmnebacteum dihtharie, Diphtheria is acquired tough personal\n\u2018contac. the incubation peiod being genaaly 2 40 5 days. Iie a\nToile disease in Malaysia. Thee sa amanshing wend in Inconce\nfom 0.11 por 10,000 papuason in 1088 to 0.02 9 1008 (Minsey of\nNeath Malaysia, 2002, eel 1)\nDoha toxoid i, produces by groweg C; diphtheria ino auld\n\u2018edluim Ineating the trate ath orale to conver the toa 10\ntorois, which is free purbad. and concentrated To achieve. the\nIecossary dosage. tual absorbed on to an adjuvant hor\nluminum phosphate or uminum \u2018Rydroxde. to incense. the\n[emunogonity (nstry of Health tayo, 2002, ove 1: Academy\u2019 ot\n\u2018Medicine of Malays, 200, ove). 12 Tetanus\nTetanus is an acuto disease caused ty a highly potant neuretoxn\n(etanospasmin) produced by Closrism tetany, wich acts athe\n\u2018myoneualjnction of shaotal musce, an on neuronal membranes\n{he spinal cod, Bockng inttry Impuses fo motor neurons. The\n\u2018Ssoase is characterised by mucllr #gidty wh. Sypecimposed\n\u2018gonising contactors. Th Docitas grows anaerobically of to sto of\n\u2018wounds Tetanus spores are preset inthe ol and may be invosuced\niio the body ducing Inury trough puncte wounds, bums oF tial\nvwounds. Ir not spread from person to porsn, and the Incubation\nPrsiod may vary fom 2 days to 2 months, averaging about 10 days\nSithough most cases oocur win 1\u00a2 days. Shorter incubation peiods\nfe said be assocated wih more heavily contaminated wounds, more\nSovare disease and a worse pogneats Death results Hom fospenary\n{are hypotension, or cardiaearhytmias (Misty of Heath Malaya. 2002,\" vol {American Aeaomy ot Pediat, 2000, leva! Department of Heath, Utd Kingdom, 196, lve! Natlenal Heath &\nMagical Resoarch Counc, Australi 1997, ve 1)\nTetanus is\u00bb notfabto \u00e9soase 9 Metysia, wih the reported incidence\nshowing a gonoral dimahing Wand Worn 0.08 por 100 000 popuation\nin 1988 to 0.06 1998 Minch of Heath Mays, 1900). Tetanus vaccine toxoid extracted fromthe toxin rough cute of \u00a9\nlelanc Tho col eo product's. daloxed ater Woatmont wih\nformaldehyde. and usualy adsorbed on 19 an avant (citer\n\u2018lumii phosphate \u201cor\u201d alumoiim hyeordde) wo Ieteaso\nIEnmunogensay (Misty of Helin Malaysia, 2002, vel 1: Acadamy of\n\u2018Movdeno f Malaysia, 2001, ove! 8). 1.3. Pertussis\nPanussis or whooping cough\u2019 Is highly contagious disease caused by\nBordo \u2018an anrobic. gran-negalve coccabacius. that\nInvades the epilum of to nso-pharynx, bron and brochiles\nHuman tanemission though across ope. The asymptomatic\nincuboton ptod ie 7 1 10 days (ranging tr 6 to 20 aye), flowed\nby the calartal stag of 2107 days, and nly the porxyamal cough\ntae, 8 wks, Al henna cough some cn aa\navalable since t may be underreported (Minty of Healt Malaysia,\n2002, lve! 1).", "chunk_order": 5}
{"chunk_id": "953698e5-ad2c-44a5-85c2-928332b6b85c", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "8). 1.3. Pertussis\nPanussis or whooping cough\u2019 Is highly contagious disease caused by\nBordo \u2018an anrobic. gran-negalve coccabacius. that\nInvades the epilum of to nso-pharynx, bron and brochiles\nHuman tanemission though across ope. The asymptomatic\nincuboton ptod ie 7 1 10 days (ranging tr 6 to 20 aye), flowed\nby the calartal stag of 2107 days, and nly the porxyamal cough\ntae, 8 wks, Al henna cough some cn aa\navalable since t may be underreported (Minty of Healt Malaysia,\n2002, lve! 1). System\n{hs vaccine resulod in a-dop in vacsnalon upiaka and subsequent\nFesugnce ofthe disease in many counties nthe 1980's and 1900,\nConsequently. many developed counties aro curently using the\n\u2018cobalt ports vaccine nthe inmusnsation programe\n1.4 DTP Vaccine\nCombinaton vaccines of dhther,telanus, and pertussis toxoids are\n\u2018of two types - whole call (OTP) and cota vaccine (DTaP), OTP is the\n(of Heath Malaysia HTA, 2002, ove\n2. ADVERSE EFFECTS OF VACCINES\n\u2018hore has boon mach pale once on he adverse reactions to whole\ncapers DTP vacznes, primal Tocuted on the whole co\nDtusis component of the vaecine. The side effects Include led\nStem, and anaphylans reactions. The frequent local reetions are\n\u2018rythm and indaraion wih or wahout tendemess (Cody, 190%, ve! \u20189\u00b0A nodule may occasionally be presenta he njocton se for saver\n\u2018wooks, whe stile abscostes hve been por 10 occur 6 10 10\n\u2018ies per one milion doses of DTP (MMWR, 1991, love 1)\n21 Systemic Reactions\nAla syateme reactone ko fover, drowsiness, fretness, anarxia\noccurs raquently (Cody 1981 ive! 2). Fever usualy occurs 24 hours ot\nlater atr vacinaton. However, if ho over persists for moro than 24\nouts. should not bo assumed oe due to DTP vacinaon (MMWR,\n1991, eve: MMWR, 1996; Tove! 1. Modorate-lsevere systemic evens occur nequenty and appear 10\nbe wot sequelae. These include high fevar (a omperature roar\nthan 40.5 \u00b0C), wihin 48 hours, unexplained by another cause\npsisent inconedable crying fasing for 3 hours or more, win 4\nFours of immunisaton; conapse or shocktke epsodes (hypotonic\nIrporesponsio opodo) win 48 urs occuring in asa to 1.780\noeos adminstored (Cody, 190%, lov #. or aertived convasions\n(sual febrie) occuring within 3 days (Mirsiy of Healt Malaysia,\n2002, ve: Amercan Academy of Pokaice, 2000, vel?)\n\u2018There is consistent evidence of camlaion betwen OTP vaccine and\nscute encephalopaty. although i has Seon fsulicnt lo estabesh\n\u2018ausaly (Bara, 1888, ovr &: Mier, 193, lve 8; Cowan. 1993 evel\n\u20185, Sima. casal olatonsnip betwoo OTP vac and parmanent\neurologieal damage has nol boon established (Cowan, 1989, ove 1)\n\u2018oporbng f CDC i 1078 (MMWR, 199, vel 7),\n\u2018Severe reacsons to vaccines containing diphtheria or wlanas anigans\n(OT) ae oxrmaly rare. An immediate anophyfacc reaction o tetas\n42nd dohihera toroid conlaning vaccine (e DTaP.", "chunk_order": 6}
{"chunk_id": "85c50d90-1f1d-4d0a-89a8-db84d1eaa76d", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "although i has Seon fsulicnt lo estabesh\n\u2018ausaly (Bara, 1888, ovr &: Mier, 193, lve 8; Cowan. 1993 evel\n\u20185, Sima. casal olatonsnip betwoo OTP vac and parmanent\neurologieal damage has nol boon established (Cowan, 1989, ove 1)\n\u2018oporbng f CDC i 1078 (MMWR, 199, vel 7),\n\u2018Severe reacsons to vaccines containing diphtheria or wlanas anigans\n(OT) ae oxrmaly rare. An immediate anophyfacc reaction o tetas\n42nd dohihera toroid conlaning vaccine (e DTaP. OY cr DT) is 2\nontandcaton to farther doses unos the pant can be dosonsiiced\n{a these tnads, due to uncertainty a 1 which vacene component\n(phir, portisis or tetanus) may be fesponsiio, Persone ho\n\u2018erperarce naphvacicregctons may be teered to an along for\n\u2018evavaton and poastte dosorsitzaion (Ministry of Health Malaysia,\n2002 lve! Amancan Acadomy of Pesaes, 2000, ve! 1)\n\u2018overuse of tetanus toxold can resut in polyneuropathy with an\nstates eldence of 0.& par min doses of eta toxoid (Minsky\n\u2018St Meath Malaysia, 2002, oe! 1. Despite some case reports, no increased risk of Culiain Bare\n\u2018Syndrome has boon cbsorved wih the use of Llanos toxoid in whale\nstile ead pertssavoenes Nato Healt) & Meal Research\nCounch, Astral. 1087, fool 1) once, no spocal precautons\nfooted von exnunaing charen wir a hakoy of Sultan Bare\n\u2018Synarome (istry of oak Mays, 2002 vel\n3. VACCINE EFFICACY\n3.4. Diphtheria Vaccine\n\u2018The most important factor of an ago host response to immu wh\nSphiheia toxoid isthe moving flock of postvely acqured matorral\n\u2018abodes in young intants. This passive dpiera anibodies se0m to\n\u2018how a rarsiont antibody response suppression tothe second injection\n\u2018NDT vaccine, aihough, Bre hae beon ro response To the thet\nInjecton of DPT vaccine Misr f Heath Malaysia 2002 vel). Primary immunisation with 3 doses of OTP vaccine stiulsts the\n\u2018roduction of iphthera. antbody Tove in considerable excess of the\nIrina protective lve (001 Win). However, wha tral erry\n\u2018Se long, the duration of mmunty aor a prnarynmunisation sora\n\u2018@ vaable. \"Stsios on tis fae havo sowed iorng ross, wth\n\u2018duration of immunly ranging om 3-10 years. Tis could be due to\n\u201cforce in vaccines, vacanatonschedles and aves of commu\nfxposure lo Corynebacterium dphherie presence of nalural boosting)\nIn contrast, a booster dose at 2 years or at school etry (48 yaar)\nSlates abundant reduction of Sphownaanitonn wit mean Wve\n\u2018ove 0.1 WU. There is no defined love! of anion but ls blloved\n{hat 0.07 Win dose of Oiphara a enough for clrscal immunity\nagainst the dsease, while 2 dose of 0.1 U/ml may be needed for\n\u2018rotecton Mins of Heath Malaysia, 2002, ve! 7). \u201cThe oflectvoness of 3 or more doses ranged ro 87 to 99.9% (Biogard\n\u2018t's. 2000, lve! 9; Chom otal, 2000, love! 9) Schooicren who\n\u2018ectved booster doses expaienced protecton against respiratory\n\u201cphnela (Bogard ta, 2000, ove! 8) In Rusia, was is found\nthat boosie doaos gen at 68 years provided improved grotecton\n(Vitek tat, 1999, ove 7).", "chunk_order": 7}
{"chunk_id": "aba70405-9004-4a2b-86bf-ad0223f0f185", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "There is no defined love! of anion but ls blloved\n{hat 0.07 Win dose of Oiphara a enough for clrscal immunity\nagainst the dsease, while 2 dose of 0.1 U/ml may be needed for\n\u2018rotecton Mins of Heath Malaysia, 2002, ve! 7). \u201cThe oflectvoness of 3 or more doses ranged ro 87 to 99.9% (Biogard\n\u2018t's. 2000, lve! 9; Chom otal, 2000, love! 9) Schooicren who\n\u2018ectved booster doses expaienced protecton against respiratory\n\u201cphnela (Bogard ta, 2000, ove! 8) In Rusia, was is found\nthat boosie doaos gen at 68 years provided improved grotecton\n(Vitek tat, 1999, ove 7). Thus, tis recommended that Ophir Bo\nvon 253 primary doses wth a boasar a year arth primary doses,\n{8 wol a anohor at 6-8 your of ge. 32 Tetanus Toxoids Vaccine\nTetanus owes has an eflcey of move han 95%. Elective protection is\n[rovded by active immunisation, with complete primary immanisaton (3\novos) config potecon fra east 5 you's. many wa lato\nleast 10 years aller the 4\u201d dose, and 20 years ater the 5\u201d dose\n(Misty of Heath Malaysia, 2002, eet 1. A totanus anitoxn love of 001 in! serum is considered 38 tho\nmisimum protective level (Chon, 1976, vel 1} Caso reports have\nShown thal for patents wah aationnlavet mora than 001 Wa the\nSavoy ottawa vert proportional othe aston vel,\n23 Pertussis Vaccine\nThe efecivoness of 2,3-dose whle-cal perussis vaccination was\nbetween 71 to 90% depending on the case defeaton usd (00 Serres,\n1296, love! 6) Aceblat OTP wth mare than thee component peruse\nvactnes was foun o be loss offeacous than Bose with 203 whol\n\u2018vaccines Tieion, 2000, vel 1) Mest sludes mansure peruse\nBntionn (FHA anitodies) and loves above 0.01 Ula! are concord\nto be a rosponee fo the acco, affording & minimum protacivelovel\n(iisty of Heath Malaysia, 2002, eet 1. 4. STORAGE , DOSAGE AND ADMINISTRATION. 4.1. iphtnria Vaccine\nDiphnea vaccines shoud be stored at 2 \u00b0C to 8 \u00b0C. the vaccine had\nbean zon shoud net bo 400d (ney of Hah Malaya, 2002\nlevel Academy. of Medicine of Malaysia, 2001, Jove! 9} The\n\u2018ocomaonded dose |e 05 ml given iamunculey (Maia of Malays,\n\u00a32002, ovo 1) (Grade A\n42. Tolanus Toxold\n\u201celanus toxoid Is slable and able to withstand room temperature for\ntorte (WHO, 1095 fove 1). However, tans vaccno if port of OPT\n\u2018shouldbe stored at 2-8 \u00b0C, and shows not bo tazen exposed to ight\n{Wins of Hatt Malaysia, 2002, toe! Natonal Noah & Medel\nResearch Councl, Auctaa, 1997. love! 4; Department of Health\nUnitod Kingdom,\u201d 1998, evo! 1). The. doo\u201d ie D'S mt gwen\nIntramasculty Fr primary lneunieaton olaus vaccines shoud ot\nbe given as 2 moracomoanent vacsne, bt combined wth iphhena\n(01) andor pertussis (OPT) (nity of Health Malaysia, 2002, love 7\nNatonal Hoaih & Motkcal Research Covned, Asta 1297, level)\n{Grade a)\n43. Pertussis Vaccine\nPerussis vaccines should be stored at 28 \u00b0C and should not bo fazen\n(Qtinsuy of Heath Malaysia, 2002 ove!", "chunk_order": 8}
{"chunk_id": "e850b779-7d8c-41dd-8282-210554fc9b41", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "Natonal Noah & Medel\nResearch Councl, Auctaa, 1997. love! 4; Department of Health\nUnitod Kingdom,\u201d 1998, evo! 1). The. doo\u201d ie D'S mt gwen\nIntramasculty Fr primary lneunieaton olaus vaccines shoud ot\nbe given as 2 moracomoanent vacsne, bt combined wth iphhena\n(01) andor pertussis (OPT) (nity of Health Malaysia, 2002, love 7\nNatonal Hoaih & Motkcal Research Covned, Asta 1297, level)\n{Grade a)\n43. Pertussis Vaccine\nPerussis vaccines should be stored at 28 \u00b0C and should not bo fazen\n(Qtinsuy of Heath Malaysia, 2002 ove! 1; National Health & Modal\nReseareh Counc, Austra, 1997, love! 1. Deparment of Heath\nUnited Kingdom, 1996. eve! 1}. The dose\u2019 is 05 ml gen\n\u2018namuscutary ai 9 90'engo toto skin, Tho recommended ate of\ninjecon & the antrlatera aspect of tho Wigh fr infants, wile for\ntoddlers upto 4 years of age, the dello muscle i te recommended\nsite (ACIP 2002) [rade Al\n5 ACCELERATED OTP IMMUNISATION SCHEDULE\n\u2018The fst dove of OTP at 3 month of age has bean said obo o0 lle to\n\u2018fold infants against pertussis (National Heath & Medial Research\n\u2018Counet Atala, 1097, love! 1; Bart, 1000, jot 1). thas boon shown\nthat te fst doso of OTP can be lowered to 8 wooks of age witout\n\u2018comeromising imunogeniciy, Tor both te wholo coll and. scolar\nDertussle OTP vaccines (WHO. 1005, fv; art, 1900, tovel 1,\nRamsay, 1993, vel 9: Eanards, 1005, ove! f: Gustafsson, 1096, fvel\n1). Booster doses of OTP al 12-24 monihs and at 46 yours ae\novo) ) rade Ay\nPOLIOVIRUS VACCINE\n41 IntRopucTION\nPomel is an acate val infection ranging in savory rom a non:\nspect ness fo paras with parmanent aaby. About 90.5% of\nbows infecion is asymptomatic, wo non: speci ness wth ow\n{Grado Tover and sore teat occurs in 48% cl inectons. Asopte\nmening with parastwsia occurs in 15% of patents ow says ater\nthe minor tnoss has resolved. Rapid onset of async nc Nacid\nparalysis with artiona ety lbs occurs in 0. 2% of etectons,\nand residual paralyie disease imaving the motor nowrons (paras\n\u2018oomyeits) occurs in approximately tm 250 lfectons. Cra nore\nInvclvement and paras of Tespratory muses may also occu,\nFindings of mid pleceyioss and mphocye edornance in tho\n\u2018cerebrospinal ad {CSF} are charactors of wal moningis,\n\u2018Akits who contracted paraite pollo in chided may develop\n\u2018te post goo syndrome 30-40 years late, characteeed by mince\n\u2018iin, oxacorbaton of woukness, andor new parva or weakness\nThis secondary ness resembing motor nouren disease after an\napparent stort paiog is somatmos known as lle post posom volta\n\u2018muscular atrophy. Rsk facrs that may atc ho potential for maton\n\u2018wih pollowtus or the soverty of cnicl posomyets Ince mon\nefilency. injections, maiilen, piysien achvty, pregnancy and\ntonelactomy\nFour types of poovinas vaccines are curenty aiabie - inactivated\npolo vaccino PV) of Sak, oral poo vaccine (OPV) \u2018of Sabin,\nInactvatod vaccine of Van Wess (PV) and\ncombinations wih or vaccines the DTPSPV.", "chunk_order": 9}
{"chunk_id": "a8d64cc3-718c-4f0f-a546-45fedf00138e", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "Rsk facrs that may atc ho potential for maton\n\u2018wih pollowtus or the soverty of cnicl posomyets Ince mon\nefilency. injections, maiilen, piysien achvty, pregnancy and\ntonelactomy\nFour types of poovinas vaccines are curenty aiabie - inactivated\npolo vaccino PV) of Sak, oral poo vaccine (OPV) \u2018of Sabin,\nInactvatod vaccine of Van Wess (PV) and\ncombinations wih or vaccines the DTPSPV. Tho vaccines aro\nttvalent containing a mitra of he\u2019 Sane of pokowus\n2 ADVERSE EFFECTS\nhore havo been many report of Vaccine Associated Parayte\nPotomyeits (VAPP) due \"> OPV, wth an opedomlogical stay\n\u2018estimating the tk fo bo 13 cates por milion vaccines. PV soos nt\n\u2018cause VAPP and Is curenty recommended Yo srovent VAPP in 8\nSequential regime. Howover, oer studies have reported. adverse\n\u2018vents det PV ike toca eacion a iyocton se (43%) neucloge\ndisorders (12%). hyportenson (10%) ana alergis reactone (10%)\n\u2018Other rare out sevous sido effets Iko prnistnt eying, abi seizure,\n\u2018apyete seizures, uneasiness and shock have been reported (Min\n\u2018of Meath Malay, 2002, lev! 1). 23, VACCINE EFFICACY\n\u2018Thor ie good evionce that OPV is efeacous.Chisron with darthoea\nreoching OPV should be resmmunised once the agase has resolved\n\u2018Since thas boon found that sarthona Isa major factor in vaccine fare. \u2018Th seroconversion rate forall ypes of pokovis was found to be\nhigher fan extra doso was gen at bit) if counties where\nDotiomyalt sa problem\u201d OPV ale found afectve when givan \u00a9\nDole babies at 34-5 weeks of gestation (Ministry of Heath Malaysia,\n12002, fave! {V was found 10 be as eficacous a= OPV. It was also found that\n\u2018troresponsas 10 IPV wore excatan! and uaffeced whan combined\n\u2018as obwr vaccines Into same singe. Howover. oe study found that\nthe immune response to persis wae affected by combing OTP ond\nIPV Qnty of Heath Malaysia, 2002, ve 1)\nVaccines combicng IPV vith OTP ore avalable. In adkitlon.IPV or\n(OPV can bo gen concurenty wih many oher yacones te OTP,\nHepaits BH, moasis or aR and Vario\n4, STORAGE, DOSAGE ANO ROUTE OF ADMINISTRATION\n\u2018The cold chain of polo vaccine shouldbe maintained, and both OPY\nand IPV vaccines shoud be sored Inthe rokigerator at #-10\u00b0C. OPV\nshould be stored bolow 0\u00b0C Afr thawing, i may be stored between 2. {8\u00b0C.IPV should ba stored at 28\u00b0C. \u2018The route of odministaton of OPV is by orl ops. wile IPV Is\nIntramuscaar, on, Be anterolteral aspect ot the thigh oF am oF\nsbeutaneoushy. Totracog (OPT APY) is adminstoreditamusculary 28\nDTP vaccne isan agavant\n'5. IMMUNISATION SCHEDULE\n\u2018Wo recommends tat 4 doses of OPV be gion by 14 wocks of og0,\n\u2018witha doce at bt in counts whore polompalits i sua prior. A\nZier sorval Io. doable between the fret 2 doses to avd\ninteerenco wit repicaton, \u201cthe. minimum nfenal ia most\n\u2018roumatancos being 6 wooks, The 3 dose recommended whon Do\nchi Is 6-18 monthe to completo the prmary soles, and a\nSupplementary dove gvon bore entong school ie.", "chunk_order": 10}
{"chunk_id": "2ba8f7e2-d78a-4da3-a45d-c0f87ba25071", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "Totracog (OPT APY) is adminstoreditamusculary 28\nDTP vaccne isan agavant\n'5. IMMUNISATION SCHEDULE\n\u2018Wo recommends tat 4 doses of OPV be gion by 14 wocks of og0,\n\u2018witha doce at bt in counts whore polompalits i sua prior. A\nZier sorval Io. doable between the fret 2 doses to avd\ninteerenco wit repicaton, \u201cthe. minimum nfenal ia most\n\u2018roumatancos being 6 wooks, The 3 dose recommended whon Do\nchi Is 6-18 monthe to completo the prmary soles, and a\nSupplementary dove gvon bore entong school ie. at 4-6 years of\n\u2018go For con not mmunsod i to Wt yoar of fo, 2 doges of OPV\nShould be given approsinately 6-8 waoks spar, flowed by thd\n\u2018doco 2-12 months intr. [Grade Al\nFer chideon immunised with IPV ony. the eimary series consists of 3\ndoses, The fest 2 doses shou be\u2019 given at 12 month (&-8 weeks)\nIntnvais Dogining at 2 months of ago (mawmum ago 8 wooks) and 3\n4 dose Ta recommonded 6-12 months aftr the sacond dose. A\n\u2018supplemental dose of IPV should be gen before the chld enters\nSchool fe 4-8 yours of 090. (Grade Al. 6 SPECIAL SITUATIONS,\nIPY is recommendad in special cases tke immune-conpromised\nDalonts such as Hivanfected and ther Household cortact, since OPV\n\u2018contanceated (nity of Healy Malaysia, 2002 ove! 1) [Grade A]\nHEPATITIS B VACCINE. 4. INTRODUCTION\nHepatitis 8 (HB) isa major chore via ess workuide with longterm\n\u2018omptcatons of eho and hepatocedlrcarenoma reuling hgh\n\u2018morally and morbaty.\u201d AS the woatnent i far fom sabsfacory Bo\nbest strategy is prevention. Thoes ince ace snmunsation wth HB\nocane, avoldance of aiisk Behavour and posse. sources of\nTraramission, and st adhorenee to unreal procautons and 900d\nInfection conv procodurs (Nanay of Haat Mays, 2002 ve)\nInfants who become infect by perinatal transmission have 980% Fok\n\u2018ot evoni focton and a 25% rk of eying f vr cancer Fuster,\nthlsren youngor than 5 years of ageing wih a person with hops\n8 iefocin can become ilcted va horizontal tanamssion and 380\nhavea higher kelnoad of chrom infection and subsequent cons ot\nCancer in erly adltood. In Malaysia, te eidence of Khas Jocinad\n\u2018tom 9:38 per 100 000 populaton in. 1988 to 297 per\u201d 100.000\nPopulation ip 1996, However, there are sll about milo hepatitis B\n\u2018armor inthis county or about 5% of to populaon (My of Heath\nMalaysia 2002, ove). HB immanisaion provides adequate protection in the. msjotiy of\nrecplonts and provera both versal and Borzorlal Wanamsaion. TNO\nhepatts 8 vacane contains inacvaled RepasB wus surface antigen\n(HbsAg) adsorbed eto aluminium hydroxide adjuvant. Sovera highly\nfecve and sale hepalitsB vaccines produced by recombinant DNA\n{echnology are avatable. The original plasma-derived vaccne is no\nlonger recommended (Minty of Hoa Malaysia, 2002. vel)\n2 ADVERSE EFFECTS\nHepatits 8 vaccine is genoa safe and wll floated. Tho most\n\u2018common adverse reactions ara ransient soreness and redness.", "chunk_order": 11}
{"chunk_id": "a1c2140e-5763-42d7-827d-0f0e00faadb1", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "HB immanisaion provides adequate protection in the. msjotiy of\nrecplonts and provera both versal and Borzorlal Wanamsaion. TNO\nhepatts 8 vacane contains inacvaled RepasB wus surface antigen\n(HbsAg) adsorbed eto aluminium hydroxide adjuvant. Sovera highly\nfecve and sale hepalitsB vaccines produced by recombinant DNA\n{echnology are avatable. The original plasma-derived vaccne is no\nlonger recommended (Minty of Hoa Malaysia, 2002. vel)\n2 ADVERSE EFFECTS\nHepatits 8 vaccine is genoa safe and wll floated. Tho most\n\u2018common adverse reactions ara ransient soreness and redness. at\ninjection ste, lw grade tomperstre, nausea, dzness, male, rsh,\n\u2018an iiuonzatha syndrome, onus, arthaiga and myeig, thal occur\nToss troquety in infants and crudren than adults. Those sympioms\nresoive whi 24-48 pours of vaccine administration, and te Weduentcy\nOf ese reacions decease win subsequent doses of the vacae,\n\u2018Merte ractons have been repetod infequeny nd anaphyls\n\u2018ory rar Wins of Heats layla, 2002 vel 7). Cases of GuliainBare symtoms, rheumateld atts, emyetinating\nCseases of the central neous system, and Iehonoid reaction have\nboon opted afer hepaths B emmuniaaton. However, thre Is 00\nfeidence of an association Between vaccination and sudden infant\nSoath syndrome, mitiplo scrosn. aaunmuno doaee oF GwOr:\nfigue symarome [DeBiase ot al, 2002; Amotcan Acadamy of\nPedhatis, 2000, evel 1\n\u2018Thimerosal isa derivative of ely mercury and has been used\nfroseratve in vaccines since the 1980s for fs ofleacy hn prventng\n\u2018acter contamination i opened, mul-cose containers. Theres mo\nonvining evdencn of tnt frm doses of Tamorosal sod\n\u2018acdies (MEPhps & Marcuse, 2001, eve 2)\nVACCINE EFFICACY\nHigh sorocanvorsion rates and protective concentrations of ant-Hbs\n{2tOmivim) are achieved when hepatis B vaccine s administered\nSry of ho various dose schodulos, indudig those bogun boon ater\nrth in term nan. The use ofa 3-se regimen has bean shows 1 be\ngil effeacous. The vaccine is eflctiven roveniing HB nfcon\nChdwauals who produce pectic ants Hbs (hissy of Hoss Maiayets,\n2002, evel). The immune resporse using 1 oF 2 doses ofa vaccine\n\u2018produced by one manutactwrerfolowed by 1 of 2 move subsequent\nSoses from a diferent menfactuer had been demonstrated obo\n\u2018omporablo 1 a kil couse of maraaton wath a single product For\n{hlafen wth normal immune slats, rouine Booster doses of vaccine\n\u201810 nat commended (Amarican Academy of Pediat, 2000, val 1). 4. STORAGE, DOSAGE AND ADMINISTRATION\n\u2018The vaccine shoud be stored at 2 10.8 \u00b0C. Froozing wal destoy is\npotency. The vaccine is wo, stghity opalescent quid, Any vile\nhangs in Be product such as prociptates, may incate Peorret\nStorage condtons and consequent reducton in immunogency. Such\novones \u2018spould be discarded. The dose of vaccino is 05 ak,\n\u2018smietstord rasta in the antoro-aeal igh fr neonates ed\n\u2018ants, and We dotld area fox chaaren.Admbtvaten invader\n\u2018tho buttocks has rosstod in poor mane response, and fs hus nt\n\u2018recommended, Saiancous admnsiaton wi thor vaccibes at\n\u2018Sifoent ses ie sto and eficalous (Misty of Heath Malaysia, 2002,\nlevel 1, DeBiasa et al, 2002.", "chunk_order": 12}
{"chunk_id": "a74cc557-e7ed-43e7-9073-e62615cc7fd6", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "Froozing wal destoy is\npotency. The vaccine is wo, stghity opalescent quid, Any vile\nhangs in Be product such as prociptates, may incate Peorret\nStorage condtons and consequent reducton in immunogency. Such\novones \u2018spould be discarded. The dose of vaccino is 05 ak,\n\u2018smietstord rasta in the antoro-aeal igh fr neonates ed\n\u2018ants, and We dotld area fox chaaren.Admbtvaten invader\n\u2018tho buttocks has rosstod in poor mane response, and fs hus nt\n\u2018recommended, Saiancous admnsiaton wi thor vaccibes at\n\u2018Sifoent ses ie sto and eficalous (Misty of Heath Malaysia, 2002,\nlevel 1, DeBiasa et al, 2002. level 1) In pation with a Bodin\nathesis, the rik of Bleeding ater intramuscular vaccine infection can\n\u2018be mvmized by admintraton irmodataly ator the patent receives\n\u2018placomert factor, uso of 2 23-gauge rawdle of malt, and\nSoplcton of roc presauo to the tmmuration ak for al last 2\n\u2018mules (Arorican Acadamy of Pedi, 2000, fovel 1) {Grade A)\n5, SPECIAL SITUATIONS\n5.4. Infants Born to HbsAg-Postve Mothers\nInfants bem to HDsAg-poatve meshors shouldbe claansad of blood in\nthe delvey room. Both hepats 8 vaccne and HBIG (05m\nInramascatary) shoud be given simstancounly at aeront silos a8\n\u2018oon as possible, prefrabiy win 12 hous afer bith. Subsequent\n\u2018doses of Popatis B vaccine shall be gon as fecommondod\n5.2. Preterm infants\nFor prot ifnts wo weigh lass than 2 kg a bit he ni vacing\ndose shoud not be counted in the required 3-dose schedule. Thus. a\ntotal of coaoe are recommended in bis secumstance, These infants\nShould be losted serlogealy Yor antsHBs and Haag 1 19 3 mons\n\u2018fer compton of tho munsaton series. Infants with ant Hs\nConcentrabone of less than TOmiUiml and who are HOsAg gave\nShould reenve 3 acatonal doves of vaccine at 0, 1 and 6 mons\nTotowed by testing for antMBS 1 month ater to ted dose (DeBiava ot\nal 2002, American Academy of Pediat, 2000, level 1.) {Grade A)\n5.3. Serologic Testing\n\u2018Suisapitaty tsting efor immunisation i no ndcated routinely for\nchron or adolascons, Roun post-inmunisaton testing for an-HBS\n\u2018is alco net nocessary. Howovor, tasting i adised 1102 months afer\ntho third vaccine dove for patios on hemodialys, persons wi) HIV\nInfocton, nose a occupational risk of exposure fom sharps injsies,\nImmunacompremised patents at risk of exposure. to HBV. rogdar\nSonal contacts of HbsAg-postve persons, and infants bor to HOSA\nostive motors (American Academy of Pants, 2000, love 1 )\n{Grade A}\nWAEMOPHILUS INFLUENZAE VACCINE\n4. INTRODUCTION\n\u2018Haomophlus intuenzae is a respiratory pathogen of humans causing\n{nfoctors ranging tom asymptomatlealonzation of tho. upper\nrespirator tract lo serous invasive dsease is an important patiogen\nin-ehren causing consterabe morbidity, morally and bwalth care\nfxpense, both workwide and locally (Minit of Mealh Malaysia, 2002,\ntowel\nlieasive disease is associated with encapsulated strains of the\n\u2018organism.", "chunk_order": 13}
{"chunk_id": "2a596e11-a58a-49c3-8f50-e019c6663aa9", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "to HBV. rogdar\nSonal contacts of HbsAg-postve persons, and infants bor to HOSA\nostive motors (American Academy of Pants, 2000, love 1 )\n{Grade A}\nWAEMOPHILUS INFLUENZAE VACCINE\n4. INTRODUCTION\n\u2018Haomophlus intuenzae is a respiratory pathogen of humans causing\n{nfoctors ranging tom asymptomatlealonzation of tho. upper\nrespirator tract lo serous invasive dsease is an important patiogen\nin-ehren causing consterabe morbidity, morally and bwalth care\nfxpense, both workwide and locally (Minit of Mealh Malaysia, 2002,\ntowel\nlieasive disease is associated with encapsulated strains of the\n\u2018organism. There ar sx capsular sortypae dvignaled of, he may\nOf invasive dasases being causod by Hoomophius Inivenza0 type 8\n\u2018MeningitsIs o most common invatve Hemogius iatuonza type B\n{WH0) ntecton\u201d Most cases of He meninglts in Malaysia cea nt\n\u2018hacken onder 12 montis 0. and ils rarely encountred in ose\nLindr'3 montis and beyond yrs of age (Misr of Heal Malays,\n2002, ove 7)\nTho Hi vaccines avatable presently consist of polbosyibito! \u2018hosphato (PRP) chemically inked (conugatod) to a vary of car\nbros Th care tenes\u00bb goed andy respons he\nip capsular polysaccharide, Four types of vaccine ae. svallabie \u2014\n[PRP-ouer mambrane prooin conjugate vaccine (PRP-OMP), PRP. tetanus taxed connate (PRP), PRP-Hib oligosaccharide conjugated\n\u2018cane (PRP-HLOC) and PRP-phtwia tox. conjugate. vaccine\n(PRP-D- of hich only the fest are caeily avaiable in Malaysla\n(ity of Health Malaysia, 2002, ove! 1),\n2. ADVERSE EFFECTS\n[Adverse reacions to Hi conjugate vaccines are few. mostly pain,\nfednass, ond aweing al Inecion sto, occuring In about 525% 0\nfecblons. \"These symptoms ae mid nd as for oes than 24 Fours. \u2018Sytem roactons such as tover and rab aro requont(Menity\nof Heath Malaysia, 2002, eve). \u2018The combination vacine (OTwP +H) Is wll lrated by infants and\nfo sigaiicart sidefocs havo been reported (Mristy of Health\n[atayia, 2002, lovel 1: Hussey, 2002, Cheon, 2002: Are, 2000). \u2018Tho Toca reactions reported were mainy. ansiet pain. reds,\nInduaion and somo low grado fover (Loko. 2001). No vaccine:\nTalated serous adverso ewonts have occured when (OTaP-PV) and\nHH vaca aro od, efthar whan moxod i the samo Syringe or givan\n\u2018Seporaty (Keutsson, 2001). blower incience of adverse events has\nono martin\n\u2018been reported folowing he HbDTaP combination vaccine compared\n10 he Mabe T WP (Gyea, 2000, evel 8\n3. VACCINE EFFICACY\nThe protctvo euporonty of any one othe thrve vaccine \u00ab PRP-T,\nPRP'OMP and HBOC \u201d has not been demonstrated, and ffca\u00b0y\n\u2018sues inate that those vaccines are sutale Tor prevention of\n\u2018Saoace in infants and chien In fondomzed \u201ccomoled tas,\n\u2018antibody response to sme vaccines was higher alr th st doo, but\ntho levels wore nol sgnticanty diferent ater 3 doses (Mnsty of\nHealth Matasia, 2002, level)\n4. COMBINATION OF VACCINES\nEffective immunisation of chien against multe dseaso best\n{ackled by giving several ansgans in one injocon. The preparation of\nthe ge nection coud be done afr Sung manulactwe of vaceines\n\u2018or immediately betoreadmistvatn (Misty af Health Malaysia, 2002\nvert), DTW?", "chunk_order": 14}
{"chunk_id": "1e12d388-5e8b-4f24-9d29-8f86a59c5451", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "COMBINATION OF VACCINES\nEffective immunisation of chien against multe dseaso best\n{ackled by giving several ansgans in one injocon. The preparation of\nthe ge nection coud be done afr Sung manulactwe of vaceines\n\u2018or immediately betoreadmistvatn (Misty af Health Malaysia, 2002\nvert), DTW? mixed wth PRT and given concurreaty with OPV,\nPRP-T mid wits OTwe, DTPwIPV mixed wah Hib and separate HEV\n\u2018achieved satstactory anibody preducton against PRP (Araujo, 2000;\ninst of Hoan Malaysia, 2002, lool 1. Thar was no interference to\n\u2018ny ofthe components when OPV, OTOP and Hib vaccine wore given\nSeparately or won DTaP ray mixed wilh Wb and gen wal OPV\n(Ronnels a, 2000, vel 2). \u20185. STORAGE, DOSAGE AND ROUTE OF ADMINISTRATION\nConjugate vacins shouldbe slr at 28\u00b0C, and mus ot be frozen,\nEach dove of congugat vaccine f 0.5m and giv armen. Tho\ntie of taesonal dove regimens showed adequate serlogeal response\nSand mmunologeal memory (Ministry of Heats Malaysia, 2002. eve\nFerrandez 2000) (Grade A)\n6 scweDULE\n\u2018Thee is good evdonce that immunisation wih dee doses of PRP-T\n\u2018ncene at2, 3,4 0F2 4,6 mons fs igh sumanogenc (Minis of\nNosh Malays, 2002 ove 1) [Grade A)\n\u201cThe high elicacy of PRP-T oven in infancy and vetual Seappearance\nof th dso inthe UK, suggest thatthe booster dove may nol Be\nFequred fo a popuaton here high vaccination coverage (\u00b090%)\nSachieved (nist of Hoalt Malaysia 2002; love! 1: Heath, 2002),\n{Grade Al\nA single Hi vocdne dose is efficaclous in peoventing Hib invasive\n\u2018disease incon between the ages of 1-4 year. The nee for catchSp shoud always be conidored when vodkeng Mb vac in routine\n\u2018rmunsation programs (Gal, 2002) (Grade Al\n7. SPECIAL SITUATIONS:\n7.4 Promature Babies\nAough most imal infos may show an inadequate\n\u2018response {othe fl rmunisation, mary oto nants bat om\n\u2018ccnaton hen Immunisation is\" \"commenced at the. same\nrondogica \"age as tom infants (Krstonsen, 1006; -Amwrican\n\u2018Acadeny of Poatics, 2000, val 1). {Grade Al\n7.2. Thalassaomia and Splenectomy\nib conjugate vaccine fs immunogenic a patents wth Thalassomia\n\u2018major srespective af whether or nota splenoetmy had Boon porto. However. the ead as well asthe tmeg of Soostr vaccinaton 10\n\u2018maintain tng-arm immunity hos 10 be assessed (Cimaz, 2001 ev 9:\nKtstensen, 1904, level & rosin, 1992, ove 8). (Grade C)\n73 HIV Infection\nThe eflectvenoes ofthe Hb conjunated vaccine has bown found fo be\nreduced in HIV infected tors (Read, 1898, evel 8; Gib, 1985, 1096,\n\u2018evel & Rutsen, 189, fvel& Poles, 1896, eel 9, Madhi, 2002 ove! {Thay wore found to have Were beiow tho protcivn love at 1 year,\nfd thm, tho need for ronson of chase with HIV \u2018nection\n\u2018gaint Hib requires tutor ovluaton (Gb, 196, lve! 8). (Grade C)\nMEASLES, MUMPS AND RUBELLA VACCINE\n4. INTRODUCTION\n44 Measles\nNason ta bighy infectious veal (RNA) soase anda major host\n\u2018ssuo. It afects almost tho entre population in the sbsence of an\nlmmenieaton programme. Measles is wansmitled vimarly. by\n\u2018ospratery drops fm person to person.", "chunk_order": 15}
{"chunk_id": "04048ea5-69c3-47ed-b641-985b98844aaa", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "{Thay wore found to have Were beiow tho protcivn love at 1 year,\nfd thm, tho need for ronson of chase with HIV \u2018nection\n\u2018gaint Hib requires tutor ovluaton (Gb, 196, lve! 8). (Grade C)\nMEASLES, MUMPS AND RUBELLA VACCINE\n4. INTRODUCTION\n44 Measles\nNason ta bighy infectious veal (RNA) soase anda major host\n\u2018ssuo. It afects almost tho entre population in the sbsence of an\nlmmenieaton programme. Measles is wansmitled vimarly. by\n\u2018ospratery drops fm person to person. Prmary wraemia occurs 2-4\n\u2018dye folowing exposure win an intones socondary veer occuring\nSHY aye later Communty \u201cstutos in dovloping counties, have\nocumorted case fatasy rats of up to 15%. The mortally s highest\nIneadren under 2 years of ago, Bote who are malnourished, and hang\nin cowed conctions (Minty of Heady Malays, 2002, evel 1)\nMeasiog vaccine 1 a lve atanuatd vaccine cult in chick emByo\n\u2018ols. The woodne contains a sabisor at rakes f more heat resistant,\nHowever, after reconstiuion, at 22 \u00b0C o 25 & wil ose 50% of ts\npoteny, while Bacomes \u2018completly \u2018nactvatod m1 nour at\ntemperatures of over 37\u00b0C\n\u2018The atcacy of moans vaccine Is 5% for persons vaccinated at 12\nmona, and 92% for those vacates at 15 months of ago. A Teal\n\u2018vation of vacelne offeacy showed seroconversion rates ranging\nftom 93.7-98.9% for chidven god 8:24 month, mi alos bong bet\n{or those aged 11-28 mont (064-98 9%) than those who were 2-10,\n\u2018mond ei (08 7-98.34) (Misr of Health Malaysia, 2002, lve 1),\n\u2018Tho majorly of vaccinated induais appear to develop Ho long\nimmunity, but wating voce Induces immunity doos ext (sacondary\n\\ocrino fire) Howaver, the. moesios. that occurs. n immunised\npersons Pa boon epodod to ba mir than in hose who woe Hol\nImmunised. Tero is 2 minimum pieary vacine fare rate of 25%\nthen coud be higher the voedne were givon Bofors 12 manths of\n\u2018ge Misty of Heath Maya, 2002 ve! 7),\n12 Mumps\n\u2018enp i a paramysovrs infection. occurs primary in chien, with\n\u2018a peak ncdonco it $8 yours of age Camplcaons include pancreas,\n\u2018ophoit,orets(unateral orchis has been reported in up to 2%\npostpuberal males with cleleal manps, allhough stanly Is ra),\nhepatitis, myocardis and yews. Benign meningeal signe appear n\nUpto 18% of eases, but pormanont eequninn rar, A stows are\n\u2018Complication is uniateral nerve deaess\n\u2018Mumps vacsine is 9 ive attenuated vaccine prepared in chick embryo\n\u2018cal Gutures. The most widely Usod strana peoseat Is ert Lyn B\n(Gaksh of al, 1950), while te othr stains avaatle are Rube a\nUrabe. The Urabe stain was witharawn in 1092 ator an aseociaton\n\u2018wih increased rik of aseptic meningitis was reported in Owe counties\n(Furosz 1990). while the Rub staan has. boon shown 10 be\n\u2018Sesonated wih pemary vaca faa (Schogel, 1999)\nSeroconversion alr @ single dose of mumps vacone was reported fo\nrange tom 90:100%.", "chunk_order": 16}
{"chunk_id": "22df76cc-00ff-4ef3-ae69-91dda3d0f865", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "The most widely Usod strana peoseat Is ert Lyn B\n(Gaksh of al, 1950), while te othr stains avaatle are Rube a\nUrabe. The Urabe stain was witharawn in 1092 ator an aseociaton\n\u2018wih increased rik of aseptic meningitis was reported in Owe counties\n(Furosz 1990). while the Rub staan has. boon shown 10 be\n\u2018Sesonated wih pemary vaca faa (Schogel, 1999)\nSeroconversion alr @ single dose of mumps vacone was reported fo\nrange tom 90:100%. Tho uration of vaccine Inced nunty\ntrknown (antbedes have been shown to peril for 9'5 year afer\nMR adminstraion) ba epl\u00e9emisiogical and serolopeal data ovr the\npast 30 years inscale No perssionce of anibeces and conning\nProtecton against focton tis antepated tha a wo dove MIR pally\nWil eectvty dea with most cases of primary vaccine fale at have\n2 isk of mms in aro (Mitry of Health Malaysia, 2002, fev). 1.3. Rubella\nFuels an RNA vius belonging othe Togail\u00e9oe group of ves. [is transmitted trough doplel spread, while. cengertal infection\nects as a rosult of vaemia during rognancy. Thetarloganc etfocts\n\u2018re produced as 2 resut ofan inflammatory response toe Vins and\ndepressed mosis, resulting in hypoplasia in tho cavelping foots\nFubata associated delects occu 100% of pragnancies i inaction\noccurs in tho fst 11 woeks, 50% in infocsons at 1-12 wake 35%\n{15-16 weeks. The cammen pormanoet morestatons of congenial\n\u2018bola inode sensorineural deatnass, mortal rladaton, extarats,\ncongenital heart detec eUnopaty, spevte dplaga, gow relation,\n\u2018nepaosplenomepaly,tirombocyopena and meningoencephalic. Fuels vaccine is feeze-<ded preparation that i stored at 28\u00b0\n\u2018and when reconstuted with iver fi. Is von i dose of 0.5 mi\n\u2018Subeutaneously. A serum antbody fo rubella ts nducod In atleast 953%\nof recpents folowing 2 singe dose at 12 month of 290 oF lator. \u2018Vaccine inducodanibody as boon shown to porst fora least 16\nyears and protacton agaist cna rubala appears to be Tong term. However prenary vacono fats. do occur and anabody levels can\nwane (Mise of Hoa, 2002, love! 1). 14 MMR Vaccine\nThe MMR vaccine isa freezeciod preparation containing We\n\u2018ttonuated measles, mumps and ubala vases. 2. ADVERSE EFFECTS OF MMR\nThore are minimal adverse reactions folowing vaccination wh MMR\n\u2018natudng Wal pa, local tration, malaise, fover of a rash that\n\u2018ously cecurs a week afer inmuntaton, lostag for 2-3 days\nPotential serous complcatons inctude loathe Thronbecyepaenc\nPupusa (TP) (3.3 per 100,000), arhropaty. Keble convasions,\ntena (08 per 10 00) and parotd swing. Howover, the mums\nomponcnt of the MUR vaccine 16 hnown to be associated wih\n\u2018ments at an estimated rte of 1 in 50,000 fo Tin 1 lion doses,\ntahini for Toss common than with tho natural Hess. (118%)\n\u2018insur of Heath Mataysia, 2002, ov! 1). The current evidence only establishes a causa elation between MMR\n\u2018ciation and anaphylaxis, twombocytopona, ebro seizures, and\ncute artes. Howover, no causal bak hus boon estate tnking\nTUR fo autsm and fnfammatory Bowel dsoasos (Ministry of Heath\nMalayin, 2002, fvel 1: Madson ata, 2002: Taye ota.", "chunk_order": 17}
{"chunk_id": "18527e60-98fb-4b60-86e5-617a46aee84f", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "Howover, the mums\nomponcnt of the MUR vaccine 16 hnown to be associated wih\n\u2018ments at an estimated rte of 1 in 50,000 fo Tin 1 lion doses,\ntahini for Toss common than with tho natural Hess. (118%)\n\u2018insur of Heath Mataysia, 2002, ov! 1). The current evidence only establishes a causa elation between MMR\n\u2018ciation and anaphylaxis, twombocytopona, ebro seizures, and\ncute artes. Howover, no causal bak hus boon estate tnking\nTUR fo autsm and fnfammatory Bowel dsoasos (Ministry of Heath\nMalayin, 2002, fvel 1: Madson ata, 2002: Taye ota. 2002) The\n\u2018oneal cneaincatons to MRR vaccine ae 33 for ave vaccines\n(itinsty of Hoon Malaysia, 2002, Level 1). Athough no anaphylactic\n\u2018ean associated win\u2019 adminsvaion \u2018of MMR vaccine has\u201d been\n\u2018opoted, tus adverse event can be He eataring. Adrenaline shoud\nbe avalabie for immediate use at any sta whore vaccines oe\n\u2018admnistored in case symptoms of anaphyans occur (ACIP, 1088;\n\u2018Amescan Academy of Pocatics, 2000, Pa, 2000)\nCitron wh abrgy to e998 can saat receive MMR vaccine since the\n\u2018are, setts allege feacons afer MNF ae blloved to bo caused not\n\u2018by eng antigens, bu by oor components of tho vacine (e.g, MMR. RS\ncomponent vaccines, and ober vacines contain hsroyzed gelatin 38\n1 stablzo) (Mins of Heath Malaysia, 2002, ove),\n2. VACCINE EFFICACY\n\u2018The vaccine fs Nghtyimmunogenc wih serconversion rales of 96400% for mason, 90:100% for mumps and 09-100% for ribet\nProtecton contered by a sngle dose gien ater 12 months of age\ntong lasing in the majotiy of persons. Howaver between 5-10% of\n\u2018rccinaled dvduals may eon have primary vaczi fal oF lose\nprotection, while 99% of neds who receive two doses (separated\nBy at eas 4 weeks) aftr 12 mone of ago have long lasting runs\ntomeacls(Minstry of Heat Malai, 2002. ovo?)\n\u2018The config evdance on the offcacy of MM. yccinaton unos\n2 months of 90. Tho hase Down a suggeston tat a mmunisaion\n\u2018ates improve, maternal anibodies may wane sooner in mothers ho\n{eceived temarsaton rar than the nul dense, hence allowing\nCond maa\n{ora lower minimum age for measles and other imwunisation (nity\n\u2018of Heath Malai, 2002, eet 1. 4. STORAGE, DOSAGE AND ROUTE OF ADMINISTRATION. |i vaccine should bo store at 2\u00b0C to 6\u00b0C and must bo protected\nftom ultraviolet hgh. Reconstiuled measles vaccine Is very unstable\nand guy loses potony a room temperature afr reconstuon, ad\nonce shoud be dscardad sat used wi 8 hours even fsore fn 8\nrafigerator (ACIP, 1968). The dosage is 0.9 mi given by intramuscular\noF degp subeutansous mycin (Department of Heath, United Kingdom,\n1996) [Grade C],\n5. SCHEDULE\n\u2018A2-dose MMR is cemented obo gven at 12 months and at schoo! fnury (6 to 7 years) However, for Sabah, & is econmenced that\n\u2018monovalent measles vaccine be gon 1 ehiiren at 6 months of age,\n{lowed by MME at 12 months and at school enky (6 10 7 years)\n(WHO! ACIP 1908). [Grade A}\n6. SPECIAL srruaTiONS. |.", "chunk_order": 18}
{"chunk_id": "20752e23-b838-457f-bfea-abaefa85b0ba", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "The dosage is 0.9 mi given by intramuscular\noF degp subeutansous mycin (Department of Heath, United Kingdom,\n1996) [Grade C],\n5. SCHEDULE\n\u2018A2-dose MMR is cemented obo gven at 12 months and at schoo! fnury (6 to 7 years) However, for Sabah, & is econmenced that\n\u2018monovalent measles vaccine be gon 1 ehiiren at 6 months of age,\n{lowed by MME at 12 months and at school enky (6 10 7 years)\n(WHO! ACIP 1908). [Grade A}\n6. SPECIAL srruaTiONS. |. Measles Immunisation in HIV Infected Chien:\nHiVntctd chien, adolscants, and yours aduts witout evidence\n\u2018of severe immuno suppression should receive MMR vacsne. Th fist\ndose should be adminstored at 12 months of age. The second dose\nmay be given as eatly 35 28 days after the fst doue-In th event of an\nCutbeak inthe cormmunty, vaccination wih rmeno-valent moasios\n\\aoane (or MMR) Ie recommended for ifans as young as \u00a9 mont\n\u2018wher \u201cexposure to\u201d natural measles is considered thay. Children\n\u2018agonal before th fst bitday should be revacinated wth MMR. at\n{2 month, and an addons dove may be gen 28 days lle (AAP,\n1900) (Grado A)\n52. Steroid Treatment\nPalient who received steroids at a dose equivalent or greater than a\nprednisone dose of2 maka of boty weight pe day. of ttl of 20 mq\nBer day, oF on ater dae for antral of 1 days of longer, shud\n[void vaccnaton wilh MMR and ts component vacsnes for at aast 1\n\u2018ont afer cessation of slroid therapy Similar, Toso receiving\nDrelonged or exenshe lopea, serosa, of ole cal corlcastorod\n\u2018hrapy that causes cial er aberatery evidence of systemic emu\nSuppression, should sto ovoid vaccination wi MMR for at lost 1\n\u2018mont ater essaton of therapy. Such poreons can generaly rocco\nIMMIR. oF #5 component vaccinos, immodataly aor coBtaton of\nnine mason\ntreatment although somo prefer waiting unt 2 weeks after compton\n(of thrapy. MBIR, or Rs component vaccines, shoud not generally be\n\u2018admnistred to porsons who have 2 dloeaso at suppresses the\nInmano respons, oF those who ao roclving ether systems ot lca\n\u2018sdminustored corscostoids (ACIP 1098), (Grade Al\nRecent evidonee Indicates that high doses of immunoglobuins can\nInst\u2018 invmane response to moasion and ruse vacone for 3\nmons or more. nd Nonce, MMR vmmunisabon shou be delayed\n(ACIP 1998) (Grade A\nREFERENCES\n1. Academy of Medicine of Malaysia 2001 Maiysian immunisation\nManual, Cologe of Pacdatics\n2. American Academy of Paediatr: pickering Lk, 2d 2000 Rea\n\u2018Book: Report ot the cometoo on infectious Diseaeas 25\u00b0 08. ER\nGrove Vitae. 3 Bakshi SS, cooper Lz (1090) Rubella and mumps vaccine. Pood\n(Cla Nm. 373), pp 691-67\n4 Bara LI. Sholds WD & Bockwth L (1983) infants and edron\nwh convulsions and hypotonic hyporesponsive epeodes flowing\n\u2018ohthera-ttonie pers immuniston, Palace, $1, 99 78S. 708\n5S. Bat Ki, Lin KF, (1990) Vaccine. preventable. dase. and\nImunisason inthe Sevelping world Pedow Cin M Am, 373) PP\nToetse\n{6 Blsgard KM eta (2000) Diptnheria vaccine afectvenes: A case\n\u2018onl! study im Russi.", "chunk_order": 19}
{"chunk_id": "1778daad-c035-44ab-b59b-9de0604947df", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "American Academy of Paediatr: pickering Lk, 2d 2000 Rea\n\u2018Book: Report ot the cometoo on infectious Diseaeas 25\u00b0 08. ER\nGrove Vitae. 3 Bakshi SS, cooper Lz (1090) Rubella and mumps vaccine. Pood\n(Cla Nm. 373), pp 691-67\n4 Bara LI. Sholds WD & Bockwth L (1983) infants and edron\nwh convulsions and hypotonic hyporesponsive epeodes flowing\n\u2018ohthera-ttonie pers immuniston, Palace, $1, 99 78S. 708\n5S. Bat Ki, Lin KF, (1990) Vaccine. preventable. dase. and\nImunisason inthe Sevelping world Pedow Cin M Am, 373) PP\nToetse\n{6 Blsgard KM eta (2000) Diptnheria vaccine afectvenes: A case\n\u2018onl! study im Russi. Journal of fectiousdsoase, 181 (supp),\npps 166-187\n7. Contes or Disease Conte (1991) Dptheris, totus, and porta:\nrocommendatons fr vacene ws and otter provenive mossiresrecommendatcn of ho Imunsavon racten Aawnary Commnton\n(ACIP) ANav 40 (ro. FFE 10). 8 Centers for Dsoase Corl (1996) Update Vaccine Side Ect\n\u2018averse Reactons Contandatone and\u2019 Precautions\n\u2018Recommendatons of the Advisory Committes on Inmunisation\nProctons (ACIP) MMR. 48 R12. 1.38\n8. Chan Reta (2000) Uieano 1982: Fst assossment of iphtharia\nvaccine affectvoness during the recent osurgonce of aphihaia\nthe former sowel uso, ourna of inectous disses, 18( spp 1),\npps 178-165,\n10, Gimaz R, Mons! C, Angulo E, Fanta E, tone V, Blase LR,\n{GaroliV, Zanoti AR (2001) Safty aed immunogenicity of 2\n\u2018conjugn vacane against Hawmophius iniuenzae ype b capsular\npolysocchaidetotanus vaccinaton related ob numbor of\n\u2018osos administration. J nie Dis, 1812) Jun 15, pp 1810-21\n11, Cody Ci Bara LJ & Cheny JD (198%) Notre and rates of adverse\n\u2018eacons with OTP and DT immunisation i iat and care,\nPediat, 68, pp 630-060\n12 Cowan LD, Grif MR, Howson CP & Kate M (1093) Acute\n\u2018encechslopahy und chronic neurckogical damage aller petusist\nvaccine. Vaccin, 11 (14) Nov, pp 1371-9\n13, De Serres G,Boulane N, Owval8 et a, (1906) Effectiveness of\nwhole call partes vaccine child care centes and schools\nedit infct Dis J, 15(6). Jun, pp 510-24\n15,\n16. w. \u20182. 19. Ea\n2\n2. 2\nEa\n\u2018eBiasa RL Daley MF, Simoes EAF (2002) Immunisation. (Curent\nPediat icgnoss And Treatment)\nDeparment of Health, nied Kingdom (1996) tmmenisation\n\u2018against infectious isease (\"The Gren Book): WMISO. Edwarss KM Meade BD, Decker Nd ta, (1995) Comparison of\n13 acobulor pertussis vaclnes: overt and sarlogc response\nedits, 86 (9 pt 2), 546-5? Fronkal LO (1900) Ravine immunsation for American chien in\n\u2018he 1990s. Ped CHAN Am, 37(9). pp 531-547\nForos J, Conroras G, (1990) Vaccine latod murs meningiis~\nCanada. Can Dis Why Rop. 1680), Dac 15, pp 283-4\nGatarka AML (1993), Tho. mmunciogies! bass for immunisation\nSoros: Mode 2 Diptera, WHOFEPger 0.13. Galazka AM (1993) Tho nmundogia! bass for immonisaton\n\u2018ovioe: Module 3-Totanus, WHIOTEPUgeN 00.13,\nGallo G, Cet Dogt tM, Cerquet M, Plovesan C. Tozzi AE,\n\u2018Salmaso S 2002} pet of aegioal Hb vaccination programme\n{ntaly. Vaccine, 27), Jan 15, pp 2985\n\u2018Gib 0, Spout V, Giscomat A. Gifts H, Masters J, Msbah S,\nNokes L, Pagharo'A, Gaqurto Krol 8, eta.", "chunk_order": 20}
{"chunk_id": "98c6f54a-e58b-4f07-89f0-17fc3a3dcfdb", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "Ped CHAN Am, 37(9). pp 531-547\nForos J, Conroras G, (1990) Vaccine latod murs meningiis~\nCanada. Can Dis Why Rop. 1680), Dac 15, pp 283-4\nGatarka AML (1993), Tho. mmunciogies! bass for immunisation\nSoros: Mode 2 Diptera, WHOFEPger 0.13. Galazka AM (1993) Tho nmundogia! bass for immonisaton\n\u2018ovioe: Module 3-Totanus, WHIOTEPUgeN 00.13,\nGallo G, Cet Dogt tM, Cerquet M, Plovesan C. Tozzi AE,\n\u2018Salmaso S 2002} pet of aegioal Hb vaccination programme\n{ntaly. Vaccine, 27), Jan 15, pp 2985\n\u2018Gib 0, Spout V, Giscomat A. Gifts H, Masters J, Msbah S,\nNokes L, Pagharo'A, Gaqurto Krol 8, eta. (1096) Anlbody\n\u2018Gib 0, Gacomell A Master 3, Spouou V, Rupa E. Gafihs H\n\u2018rol & Giaqunto C, Goiabiat 0. (1998) Persstonce of anibody\n\u2018esponses to Haemophilus infuonzae\u2019 type b polysaccharide\n\u2018conjugate vaccine. in chilean \u2018ath vorcaty ccuived human\n\u2018ewmunadescioney virus infocton. Pediat infect Dis J 1512) Dae. 5p 1097-105,\n{Guttsson t, Halnder HO, Ot pat al, (1996) A controled Wil ot\ntwo senor vaccines and one wholo-ol vacone against pertussis\nEngl Med, 934) Feb 8, pp 341-8\nKeistorson_K ($998) Vaccination of splenactomised chile,\nSntbedy response to Haomaphis Intuonzae type D conjupao\n\u2018coin, Upesks Laoger, 1552), Jan 10, pp 1873\n{oteina 8, Hiarchote A Simasathian 5 (2001) Salty and\nImmunogen of combined or associated administration of PRP-T\n\u2018cone wah dphtvera, tefnus and pertuse vaccine In. Thal\nhlsren. J Top Pediat 471), Feb, pp 269,\n\u2018Mas SA, Petoeson K. Koos Mt, Huebner RE, Mba N. Moshupi\nR Saloon H. Crowe Brown 1. Klugman KP (2002) Reduood\n\u2018ffectvonmss of Haomphis infuenzae type \u00a9 conugate vaccine\nIn enadron wth a igh previo of human immunodetency wast\ntype tintoctn, Peay Infect Dis 218), Ap. pp 315-21\nsins mma\nMadson KM, Hid A, Vestorgaard M, Schondel D, Wola J\n\u2018Thorson P, Olan J, Maye M (2002) MMR vacenalion and\nauism=2 population-based folow-up sudy] Ugeskr Laager\nfeuds) Dec 2 pps7aid\nMePhiles Marcuse EK. (2001) Vaccine Safely. Curr Probl\nPedi 31(8) Agr, pp 01-21\nger, Maage'N, Diamond J, Wadsworth J. Rose \u20ac (1999)\nPertsisimmuniston and sotaus sete neurolegical anoseags In\nhadron. BM 3076919). Nov 8. pp 1171-8\nMistry of Health Malaysia (2002) Chidhood Immunisaton. Healt\nTectnlogy Assasamont\nMMWR \u201cUse of Diptera Toxod-Tetanus Toxoid-Acelar\nPertussis Voccio as a Fvv-Doso Sarios. Novembert7, 2000 7\n45RR13) 18\nMoridty.& Mortaity Wookly Roper. (1906) Progress. foword\n\u2018olomyats eradicaton People's Repubie of China, 1990-1996,\n44940) op 1076-9\nMatidiy & Mortatly Weekly Report. (1987) Progress foward\nolomyatseraicaton Aca, 45 (15, pp 321.5\nMotidty & Moray Woely Report. (1888) impact of sequent\nIPVIOPY schedule on vaccination coverage levels Unied Sato 7\n(a7 pp 10179\nNNatonal Heath and Medical Resoarsh Counct, Austata, (1997)\n\u2018astraton Immunisation hand book \u00a9 ndon\nPetors VB Sood SK (1096) Immunity to Haomephits inoenzae\nype b polysaccharge capsule ator vaccination wth the complote\nnos of oigosaccharide CRMIG7 conga vocine infants wth\nhuman immunodeficency virus infecton. J Poa 28(3), Mae,\npp 0005. Ramsay MEB, Rao M. Begg NT ot al,(1098) Antibody response to\n\u2018accelerated inmunision wih dphthera, atanus, parssie vaccine.", "chunk_order": 21}
{"chunk_id": "2926bdc7-abb0-4af0-b90b-e58488dd0c33", "source_document_filename": "CPG Childhood Immunisation_cleaned_ultra_minimal.txt", "source_document_title": "CPG Childhood Immunisation cleaned ultra minimal", "text": "(1987) Progress foward\nolomyatseraicaton Aca, 45 (15, pp 321.5\nMotidty & Moray Woely Report. (1888) impact of sequent\nIPVIOPY schedule on vaccination coverage levels Unied Sato 7\n(a7 pp 10179\nNNatonal Heath and Medical Resoarsh Counct, Austata, (1997)\n\u2018astraton Immunisation hand book \u00a9 ndon\nPetors VB Sood SK (1096) Immunity to Haomephits inoenzae\nype b polysaccharge capsule ator vaccination wth the complote\nnos of oigosaccharide CRMIG7 conga vocine infants wth\nhuman immunodeficency virus infecton. J Poa 28(3), Mae,\npp 0005. Ramsay MEB, Rao M. Begg NT ot al,(1098) Antibody response to\n\u2018accelerated inmunision wih dphthera, atanus, parssie vaccine. neat 2 pp 208\nFReod 15, Frasch CE, Rich K, Fitzgerald GA, Clemons JO, Pit\nPetion Si, Hanson 1C, Handelsman \u20ac. Ola \u00a9, Fowior MG. (1998)\n\u2018The immunogenicity of Haomephius influenzae typo b conto\n\u2018vaccine i earn born o human mamunodoticenty veut\u2019\nwomen, Woman and infants Transmission Stody Group. Pedr\nInet Dis J 178), May, pp 30-7\nFRennls MB, Englund JA. Borstoin Ol, Losonsty GA, Anderson\nEL Picichoro ME, Munoz FM, Wolf MC. (2000) Dimnuton ofthe\n\u2018ani-pohrbosyibil phosphate response io a combined diphhera\n\\elanus aco petusisMaemophius infuenzae type b vacrine\nby concarront activated polown vaccination, Pea Inect Die\n195), May, pp $17.23. an\n4%\n49,\n46,\na\n48\n40,\nst\nutstin RM. Rudy BJ, Caan A. (1996) Response of human\nlmiurodefeiency \"vrus-exposed and. -ifeciod infants 10\nHaomophis infuenzae type b conlugate vaccine. Arch Pedr\n\u2018Adolse Med. 150), ug, pp 838-4\nSedaghatian MR, et a1986) Backs Calmote Guerin vaccination\nin rotor nfs: In J Tubere Lng 0i8.2 (8), No, pp 670.82,\nTaylor B. Miler E. Uingam R. Andrews N, Sinmos A, Stowe J. (2002) \u201cMeasles, mumps, and rubela vaconation and bowel\n\u2018roblems cr developmental regression incadren with aus\nPopulation study. BN. 324 (7394). Feb, pp 383-6,\nTheo Austratan Collage of Paodatics Pay Statement. (1094)\nCContaindcatons to krmunsaton agaist pertussis. J Paedsir\nhia Homi. 30), 4p. pp 310-1\n\u2018Tanion ON & Hanlon M(2000) Coctrane Database Systomatic\nReview (2):CO 001478\n\u2018tok CR otal (1990) isk of dipthana among shook in\n\u2018tho Russion Federation in relation to fine sc lat vacinatin\nTho Lancet, 383, aN 30, pp 385358\n|WHO (1095) Factors aflocing tho immunogenicity of cral polo\nvaccina: a prospective evaluation in Brazl and Gambia, Wor\noath Organisation Cotaboraton Study Grovp on Oral Polowus\n\u2018ccine, Journal of Infectious Disease 1715), p 1097-105 |\nWHO\" (1997) Combined\u201d immunisation of infants wil orl\nInacivated pooveus vaccines: sults ofa Yandorisd tain tho\nGambia, Omen and Thaland: WHO Cotaborston Stay Group on\n\u2018ral and inatvated Poliowus Vaccnes, sou of lectus\nDivoose, 175 (spp), 5p 8 215-27\n\\WHO (1988) Genova\u2019 Global oradcaton of polonyolis by tho\n\u2018ear 2000 Word Woah Ascomtly Rosch WHA 41.28)\n{WHO Expanded Program on immunisaton. Inmunsation Poy\nWHOEPIGENEA7\n{WHO \u201cExpanded Program on Immunisaton. kxmusalon Potcy\nWHOEPIGENTS 03\n{WHO Immunization pokey (1905). Globe programme for vaccines\n\u2018and immunisation WHOFEPUGENIS.3\n\u201cZimmerman 8, Gold R. Lavi 8 (1987) Immurisaton. Prtaduato\nMedicine, 82,8): 112-7", "chunk_order": 22}
